• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

TomoTherapy Inc.

Judge nixes Medtronic, NuVasive motions in patent infringement case

March 28, 2011 By MassDevice staff Leave a Comment

Medtronic, NuVasive

A federal judge in California dealt blows to both sides in a patent infringement dispute over spinal implant technology between several Medtronic Inc. (NYSE:MDT) subsidiaries and NuVasive Inc. (NSDQ:NUVA).

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Accuray Inc., Nuvasive, TomoTherapy Inc.

Accuray CEO: TomoTherapy integration starting to take shape

March 15, 2011 By MassDevice staff Leave a Comment

ARAY logo

Accuray Inc.’s (NSDQ:ARAY) nearly $300 million deal to buy TomoTherapy Inc. (NSDQ:TOMO) isn’t closed yet, but the integration of the two companies is already underway.

Accuray CEO Euan Thomson wrote in an email to employees that the company isn’t officially beginning the process until the deal closes, but the Sunnyvale, Calif.-based CyberKnife radiosurgery device maker is already taking steps to ensure a smooth transition.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Accuray Inc., TomoTherapy Inc.

Accuray lines up $277 million TomoTherapy buyout | Acquisitions roundup

March 7, 2011 By MassDevice staff Leave a Comment

M and A Roundup

Accuray Inc. (NSDQ:ARAY) looks set to acquire radiation treatment firm TomoTherapy Inc. (NSDQ:TOMO) in a deal worth $277 million.

The Sunnyvale, Calif.-based radiosurgery company signed an agreement to buy TomoTherapy for $4.80 per share in cash and stock, a nearly 31 percent premium over its $3.67 closing price on Friday, March 4.

The companies believe their technologies complement one another in that they can serve overlapping patient populations.

Filed Under: Blood Management, Mergers & Acquisitions, News Well, Oncology, Radiosurgery/Radiation therapy Tagged With: Accuray Inc., Amgen, Gambro, Terumo, TomoTherapy Inc.

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS